Skip to main content
UCalgary scholar receives $1M toward new research into multiple sclerosis
Read more
Study finds hydroxychloroquine delays disability for least treatable form of multiple sclerosis
Read more
Award recognizes ‘a lifetime of work’ studying immune cells in the brain
Read more